首页|粪便SDC2基因甲基化检测联合FOB、CEA和CA199检测在结直肠癌早期筛查中的应用

粪便SDC2基因甲基化检测联合FOB、CEA和CA199检测在结直肠癌早期筛查中的应用

扫码查看
目的:探讨粪便黏结蛋白聚糖2(SDC2)基因甲基化检测联合粪便潜血(FOB)、癌胚抗原(CEA)和糖类抗原199(CA199)检测在结直肠癌早期筛查中的应用价值。方法:从本院采集的358例受试者粪便样本中,实施粪便SDC2基因甲基化检测,并对结果进行深入分析。进一步筛选出符合入组条件的160例患者,分为健康对照组、疾病对照组、癌前病变组和结直肠癌组,每组各40例。补充完善血清CEA、CA199及FOB检测,统计并评估各项指标的诊断效能。结果:与健康对照组及疾病对照组对比,结直肠癌组及癌前病变组的粪便SDC2基因甲基化水平、FOB阳性率以及CEA、CA199的表达量均呈现显著性上升(P<0。05)。其中,结直肠癌组粪便SDC2基因甲基化检测的阳性率最高,为85。0%;其次为粪便潜血试验(72。5%)。这两项指标明显高于CEA和CA199的检测阳性率。针对不同特征人群进行粪便SDC2基因筛查时发现,阳性率与受检者的年龄、症状表现及其地域来源存在关联性,但与性别并无显著相关性。结论:粪便SDC2基因甲基化检测是一种简便快捷、无创且灵敏度较高的新型检测方式,能很大程度上提高早期结直肠癌及癌前病变的确诊率,与常规筛查联合应用能展现出较好的诊断价值。在结直肠癌的早期筛查方面具有广泛的应用前景和重要价值。
Application of Fecal SDC2 Gene Methylation Detection Combined with FOB,CEA and CA199 Detection in Early Screening of Colorectal Cancer
Objective To explore the application value of fecal SDC2 gene methylation detection com-bined with fecal occult blood(FOB),carcinoembryonic antigen(CEA)and carbohydrate antigen 199(CA199)detection in early screening of colorectal cancer.Methods Fecal SDC2 gene methylation detec-tion was used in 358 fecal samples collected in our hospital,and the results were analyzed in depth.Total 160 patients meeting the enrollment conditions were further selected and divided into the healthy control group,the disease control group,the precancerous group and colorectal cancer group,with 40 cases in each group.Serum levels of CEA,CA199 and FOB test were examined in all patients,and the diagnostic effica-cy of each index was evaluated statistically.Results Compared with the healthy control group and dis-ease control group,the fecal SDC2 gene methylation level,positive rate of FOB and the expression levels of CEA and CA199 in the colorectal cancer group and precancerous group were significantly increased(P<0.05).Among them,the positive rate of fecal SDC2 gene methylation detection in the colorectal cancer group was the highest(85.0%),followed by the FOB test(72.5%).The two indicators were significantly higher than the positive rates of CEA and CA199.When the fecal SDC2 gene screening was carried out for people with different characteristics,the positive rate was associated with the age,symptoms and geograph-ical origin of the subjects,but not with gender.Conclusion The fecal SDC2 gene methylation is a new type of detection method that is simple,fast,noninvasive and highly sensitive.It can greatly improve the di-agnosis rate of early colorectal cancer and precancerous lesions,and can show better diagnostic value when combined with the conventional screening.It has a wide application prospect and important value in the early screening of colorectal cancer.

Colorectal cancerEarly cancer screeningSDC2 geneCEACA199

陈小朝、卢本银、付浩宇、丁楷、杨向东

展开 >

成都肛肠专科医院(四川 成都 611017)

成都市双流区第一人民医院(四川 成都 610202)

仪陇县人民医院(四川 南充 637699)

成都中医药大学(四川成都 610075)

展开 >

结直肠癌 早癌筛查 SDC2基因 CEA CA199

成都市科技局重点研发支撑计划

2022-YF05-01249-SN

2024

中国肛肠病杂志
中华中医药学会肛肠分会 山东中医药学会

中国肛肠病杂志

影响因子:0.131
ISSN:1000-1174
年,卷(期):2024.44(3)
  • 15